Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
AMC Global Media
AMCX
$481M
| $2.94M | ﹤0.01% |
63,118
+57,325
| +990% | +$2.93M |
|
3427
Xometry
XMTR
$4.89B
| $2.94M | ﹤0.01% |
50,998
-65,439
| -56% | -$4.53M |
|
3428
Anterix
ATEX
$1.85B
| $2.94M | ﹤0.01% |
48,393
+19,984
| +70% | +$1.17M |
|
3429
PUT
Constellation Brands
STZ
$22.5B
| $2.93M | ﹤0.01% |
+13,900
| New | +$3.03M |
|
|
DRAYU
3430
DELISTED
Macondray Capital Acquisition Corp. I Unit
DRAYU
| $2.92M | ﹤0.01% |
+292,500
| New | +$2.9M |
|
|
GMIIU
3431
DELISTED
Gores Metropoulos II, Inc. Unit
GMIIU
| $2.92M | ﹤0.01% |
285,570
| – | – |
|
|
IRAAU
3432
DELISTED
Iris Acquisition Corp Units
IRAAU
| $2.91M | ﹤0.01% |
292,167
+3,254
| +1% | +$32.3K |
|
|
AUTL
3433
Autolus Therapeutics
AUTL
$500M
| $2.9M | ﹤0.01% |
443,431
-281,741
| -39% | -$1.78M |
|
|
SWTX
3434
DELISTED
SpringWorks Therapeutics
SWTX
| $2.9M | ﹤0.01% |
+45,757
| New | +$3.53M |
|
|
CMRX
3435
DELISTED
Chimerix, Inc.
CMRX
| $2.9M | ﹤0.01% |
468,293
-105,934
| -18% | -$728K |
|
|
YSAC
3436
DELISTED
Yellowstone Acquisition Company
YSAC
| $2.89M | ﹤0.01% |
285,121
+250,325
| +719% | +$2.52M |
|
|
PRSRU
3437
DELISTED
Prospector Capital Corp. Unit
PRSRU
| $2.89M | ﹤0.01% |
290,000
| – | – |
|
3438
Banco Santander Chile
BSAC
$16.3B
| $2.89M | ﹤0.01% |
146,168
-44,413
| -23% | -$874K |
|
|
TBLD
3439
Thornburg Income Builder Opportunities Trust
TBLD
$705M
| $2.89M | ﹤0.01% |
+144,057
| New | +$2.9M |
|
3440
Intapp
INTA
$2.67B
| $2.89M | ﹤0.01% |
112,068
-252,111
| -69% | -$8.19M |
|
3441
BCB Bancorp
BCBP
$166M
| $2.88M | ﹤0.01% |
195,406
-66,848
| -25% | -$975K |
|
3442
CALL
Kodiak Sciences
KOD
$2.58B
| $2.88M | ﹤0.01% |
30,000
| – | – |
|
3443
Community Health Systems
CYH
$408M
| $2.87M | ﹤0.01% |
245,185
-336,352
| -58% | -$4.39M |
|
3444
Kaltura
KLTR
$212M
| $2.87M | ﹤0.01% |
+278,794
| New | +$3.29M |
|
|
HLAH
3445
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
| $2.87M | ﹤0.01% |
295,392
-13,804
| -4% | -$134K |
|
3446
Jack Henry & Associates
JKHY
$11.1B
| $2.86M | ﹤0.01% |
17,459
-21,654
| -55% | -$3.72M |
|
|
TALKW
3447
CALL
DELISTED
Talkspace Inc Warrant
TALKW
| $2.86M | ﹤0.01% |
3,716,529
+1,769,637
| +91% | +$1.86M |
|
3448
Liberty Global Class C
LBTYK
$3.62B
| $2.86M | ﹤0.01% |
97,078
-83,344
| -46% | -$2.31M |
|
3449
Cars.com
CARS
$676M
| $2.86M | ﹤0.01% |
226,000
+186,082
| +466% | +$2.35M |
|
3450
Arlo Technologies
ARLO
$1.6B
| $2.86M | ﹤0.01% |
445,487
-366,092
| -45% | -$2.28M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.